Research ArticleDepression

A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression

See allHide authors and affiliations

Science Translational Medicine  09 Jun 2021:
Vol. 13, Issue 597, eabe1376
DOI: 10.1126/scitranslmed.abe1376

Article Information

vol. 13 no. 597

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication August 2, 2020
  • Resubmitted November 19, 2020
  • Accepted for publication April 23, 2021
  • .

Author Information

  1. Peter Nagele1,*,
  2. Ben J. Palanca2,
  3. Britt Gott3,
  4. Frank Brown1,
  5. Linda Barnes3,
  6. Thomas Nguyen2,
  7. Willa Xiong3,
  8. Naji C. Salloum3,,
  9. Gemma D. Espejo3,
  10. Christina N. Lessov-Schlaggar3,
  11. Nisha Jain1,
  12. Wayland W. L. Cheng2,
  13. Helga Komen2,
  14. Branden Yee2,
  15. Jacob D. Bolzenius2,
  16. Alvin Janski3,
  17. Robert Gibbons4,
  18. Charles F. Zorumski3,5 and
  19. Charles R. Conway3,5
  1. 1Department of Anesthesia and Critical Care, University of Chicago, Chicago, IL 60637, USA.
  2. 2Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
  3. 3Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA.
  4. 4Center for Health Statistics, University of Chicago, Chicago, IL 60637, USA.
  5. 5Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, St. Louis, MO 63110, USA.
  1. *Corresponding author. Email: nagelep{at}uchicago.edu
  • Present address: Biogen, Cambridge, MA 02142, USA.

Altmetric

Article usage

Article usage: June 2021 to June 2021

AbstractFullPdf
Jun 2021533961286613

Stay Connected to Science Translational Medicine